Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

People start looking beyond pain medicine and physical therapy when knee arthritis starts getting in the way of their normal life. Mostly come to know about stem cell treatment during that research.  The whole treatment of knee osteoarthritis is still investigational, irrespective of it receiving a lot of attention in research on mesenchymal stem cells.  […]

The post Best Stem Cell Therapy Doctors for Knee Arthritis in Los Angeles appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Most people find out what care costs the hard way, somewhere between the third phone call and the first statement in the mail. The number quoted on the phone is rarely the number that arrives later, and the gap between them is where most of the confusion sits. Care is priced in pieces. Assessment, therapy […]

The post What You Should Know About the Real Cost of Mental Health Treatment appeared first on Medical News Bulletin.

The American College of Rheumatology has updated clinical guidance recommendations for the management of osteoarthritis.
“These updated recommendations recognize that there is no single treatment pathway that fits every person living with osteoarthritis,” Sharon L. Kolasinski, MD, principal investigator at the Perelman School of Medicine, University of Pennsylvania, said in an ACR press release. “Our strongest recommendations continue to center on helping people build confidence in managing their condition, remaining physically active and pursuing weight loss when appropriate. At the same

LONDON — The Zeiss AT Lucia toric, a member of the Lucia IOL family, provides good rotational stability, visual quality and patient satisfaction, according to a presenter at the European Society of Cataract and Refractive Surgeons meeting.
“I am happy to be one of the first surgeons to have the opportunity to implant this,” Felix Rombold, MD, chief medical officer of Südblick Augenzentren in Germany, told Healio. “I have been using the Lucia platform for many years. Our team has implanted over 60,000 Lucia IOLs, and the toric is a great opportunity for us surgeons and patients.”
{{VIDEO}}
The AT

A 40-year-old Pennsylvania woman who died Saturday likely had measles and was not vaccinated against the disease, a county coroner confirmed to Healio on Monday.
Jefferson County Coroner Greg Furlong told Healio he has “good, conclusive evidence” that the woman had measles, calling it a “probable” case.
Results of a post-mortem test have not yet come back, but Furlong described it as a “measles-associated death.”
The woman lived in the county, a rural area northeast of Pittsburgh. It is the third Pennsylvania death connected to measles this year. The other two

Adolescents with sickle cell disease who use problem-focused coping strategies and have increased social support have significantly higher levels of transition readiness from pediatric to adult healthcare.
Clinicians, healthcare teams and institutions have a “responsibility” to help patients develop these coping strategies so they can have better future outcomes, Apoorva S. Iyengar, MD, pediatric rheumatology fellow at Ann & Robert H. Lurie Children’s Hospital of Chicago, told Healio.
“There are aspects of the transition process that we can support in our young adults,” she said.

The evidence tying GLP-1 drugs to nonarteritic anterior ischemic optic neuropathy warrants “ongoing vigilance” and caution in patients with any form of vision loss, according to a review.
“GLP-1 receptor agonists are now being prescribed extraordinarily widely, so optometrists will inevitably see increasing numbers of patients taking them,” author Helen V. Danesh-Meyer, DNZM, FRSNZ, FRANZCO, MD, PhD, professor of ophthalmology at the University of Auckland, New Zealand, told Healio. “There is an emerging signal suggesting an association between GLP-1 receptor

The FDA approved Joenja, also known as leniolisib, for treating activated phosphoinositide 3-kinase delta syndrome in children aged 4 to 11 years weighing at least 27 kg, according to an agency notice.
The notice highlighted that this is the first treatment approved for activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency caused by variants in PIK3CD or PIK3R1, in this age group.
For patients with APDS aged 12 years and older, 70 mg Joenja (Pharming) oral tablets are taken twice daily per the FDA’s approval in March 2023. Joenja oral tablets are also taken

MONTEREY, Calif. — Ophthalmologists are most accurate at making referrals for thyroid eye disease compared with other specialists, according to a study presented at the Women in Ophthalmology Summer Symposium.
Emma Tsai, MD, and colleagues wrote that the combination of symptoms in thyroid eye disease (TED) requires a collaborative approach from a team of physicians.
“These symptoms often require multidisciplinary care including oculoplastic surgery, neuro-ophthalmology, strabismus surgery and endocrinology,” they wrote in a poster presentation. “Referral to appropriate providers is crucial for

Patients with asthma or COPD who used semaglutide for type 2 diabetes experienced significant reductions in their exacerbations, according to an abstract presented at the European Respiratory Society International Congress.
Exenatide and dulaglutide were associated with reductions in exacerbations as well, Chloe I. Bloom, MBChB, PhD, MSc, clinical associate professor in respiratory epidemiology, National Heart and Lung Institute, Imperial College London, and colleagues wrote.
“Conditions such as type 2 diabetes and excess weight are very common in people with asthma and COPD and are linked to